Warner Chilcott, Barr settle Femcon Fe patent challenge (PharmaBiz)

Warner Chilcott, Barr settle Femcon Fe patent challenge (PharmaBiz)
Warner Chilcott Limited announced that its subsidiary Warner Chilcott Company, Inc and Barr Laboratories, Inc, a subsidiary of Barr Pharmaceuticals, Inc, have entered into a settlement and license agreement to resolve the pending patent litigation involving Warner Chilcott’s oral contraceptive product, Femcon Fe.